Examples of using Regeneron in English and their translations into German
{-}
-
Colloquial
-
Official
-
Ecclesiastic
-
Medicine
-
Financial
-
Ecclesiastic
-
Political
-
Computer
-
Programming
-
Official/political
-
Political
May 8, 2008- Bayer HealthCare AG and development partner Regeneron Pharmaceuticals.
we are looking forward to developing a potential combination therapy together with Regeneron.
Ionis and Regeneron were modestly increased.
With this filing, Bayer and Regeneron hope to make a significant contribution towards alleviating the impact of this disease in the future.
The court assumed that Regeneron did not submit these documents with the intention of deception to the examiner of the patent in suit.
About Regeneron PharmaceuticalsRegeneron is a biopharmaceutical company that discovers,
Alnylam received USD 400 mn upfront cash and Regeneron will invest an additional USD 400 mn in newly issued Alnylam shares and milestone payments.
A second study led by Regeneron, named VISTA-DME, is expected to begin later in 2011 in the United States,
for a combination therapy, and we are looking forward to working on it together with Regeneron.
From Regeneron's tactics during the litigation proceedings concerning the determination of the intention to deceive, the court concluded against Regeneron, that Regeneron was likely to have deceived the Patent Office during the examination proceedings.
Bayer HealthCare and Regeneron are collaborating on the global development of the VEGF Trap-Eye for the treatment of wet AMD,
grant of the patent, a third party filed a submission with the USPTO against a parallel application of Regeneron citing three pre-publications.
The VIEW 1 study, which randomized 1217 patients, is being conducted in the United States and Canada by Regeneron under a Special Protocol Assessment(SPA)
About Regeneron PharmaceuticalsRegeneron is a leading science-based biopharmaceutical company based in Tarrytown,
Regeneron also holds a partnership with Sanofi, with whom they have commercialized four products thus far and, more importantly, have a deep pipeline of assets the two partners are co-developing.
existing portfolio holdings exceeded cash received from exiting our positions in Regeneron and profit taking in existing,
equally the profits from sales of EYLEA. In Japan Regeneron receives a percentage of net sales.
Ionis and Regeneron and built further stakes in Akcea Therapeutics and Voyager Therapeutics.
trial lawyer of Regeneron responded that he did not understand what the court meant by that and how the claim was to be broken down.
When the court ordered Regeneron to hand over all documents relating to Dr. Jones Memo,